Evidence map›Paper›PMID 34869942›Full record

ArticleClinical epidemiology and global health

From black to white: A roadmap to containing the rise of candidiasis amidst COVID-19 and mucormycosis in India.

Faisal A Nawaz, Sadia Yaqoob, Abhishek Sharma, Abdul Rahman Khan, Sudhan Rackimuthu, Behram Khan Ghazi, Uzzam Ahmed Khawaja, Mohammad Yasir Essar

Abstract read
In one paragraph

Article in Clinical epidemiology and global health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Faisal A NawazCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Sadia YaqoobJinnah Medical and Dental College, Karachi, Pakistan.
Abhishek SharmaKing George Medical University, Lucknow, India.
Abdul Rahman KhanCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Sudhan RackimuthuFather Muller Medical College, Mangalore, Karnataka, India.
Behram Khan GhaziPunjab Medical College, Faisalabad, Pakistan.
Uzzam Ahmed KhawajaJinnah Medical and Dental College, Karachi, Pakistan.
Mohammad Yasir EssarKabul University of Medical Sciences, Kabul, Afghanistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With numbers of active COVID-19 cases in India falling in recent weeks and the healthcare system finally showing signs of coping with the mucormycosis epidemic, several new reports of COVID-19 cases linked to "white fungus" have emerged. This has led to rising concern with the potential to stretch the capacity of an already burdened healthcare system. Moreover, the implications of this disease in the COVID-19 population and its consequences on the health and socio-economic structure of the country have not been vastly studied. This commentary explores the need for government efforts in the context of containing candidiasis during the pandemic and provides key recommendations on combating this imminent public health challenge.

Indexed as

CandidaCOVID-19IndiaMucormycosisWhite fungus

Identifiers

PMID34869942
PMCPMC8634736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.